Dog /
FDA CVM · 2025 release 19 reports on file

Akbash Dog - FDA Adverse Event Profile

Adverse-event records for Akbash Dog (Dog) from the FDA Center for Veterinary Medicine.

Verify with FDA CVM →
Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 2 1.5 1 0.5 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Akbash Dog drawn from FDA CVM filings.

Data updated June 2026

The record at a glance

Among dog breeds, Akbash Dog is #367 by FDA report volume; 10.5% of its 19 reports (2) were death-coded.

#367
most-reported dog breed
10.5%
death-coded report share
3
Lack of efficacy (ectoparasite) - flea - top reaction
5.2 yr
average age at report

Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.

Total Reports

19

FDA CVM filings

Deaths Reported

2

of 19 reports

Death Rate

10.5%

death-coded share

Avg Age at Report

5.2 yr

44.8 kg avg weight

Death-Coded Outcome Share

Akbash Dog death-coded reports 10.5%
Cross-breed median

10.5% of 19 akbash dog reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 44.8 kg (98.8 lbs)

Top Reported Reactions

Lack of efficacy (ectoparasite) - flea 3
Vomiting 2
Fever 1
Alopecia 1
Unexplained death 1

Most Referenced Drugs

Oclacitinib Maleate 2
Fluralaner Chew Tablets 2
Milbemycin Oxime + Spinosad 2
Spinosad 2
Amoxicillin (As Trihydrate); Clavulanate Potassium ( K-Clavulanate) 1

Outcome Breakdown

Outcome Unknown
8 (42.1%)
Ongoing
5 (26.3%)
Recovered/Normal
3 (15.8%)
Died
2 (10.5%)
Recovered with Sequela
1 (5.3%)

Gender Distribution

Male 11 (57.9%)
Female 6 (31.6%)
Unknown 2 (10.5%)

Reports by Year

Year Reports Trend
2014 1
2015 1
2017 3
2018 2
2019 2
2020 2
2021 2
2022 2
2023 2
2024 1
2025 1

Akbash Dog Pet Health Insights

Akbash Dog accounts for 19 FDA adverse event reports, ranking #367 by volume among dog breeds, with 2 reports (10.5%) coded as a death outcome. Mean age at report: 5.2 years, average weight 44.8 kg (98.8 lbs).

Top reported signs: Lack of efficacy (ectoparasite) - flea (3), Vomiting (2), Fever (1). Most-referenced drug: Oclacitinib Maleate (2 reports), followed by Fluralaner Chew Tablets (2) and Milbemycin Oxime + Spinosad (2).

Outcome coding on 19 status-recorded reports is dominated by Outcome Unknown (42.1%). Annual submissions ranged 2,014-2,025 across 11 years on file.

Dog Breeds With a Similar Report Volume

Frequently Asked Questions

How many FDA adverse event reports involve Akbash Dog?
There are 19 adverse event reports involving Akbash Dog in the FDA database, with 2 reports involving death (10.5% death rate). Akbash Dog ranks #367 by report volume.
What are the most common adverse reactions reported for Akbash Dog?
The most commonly reported adverse reactions for Akbash Dog are Lack of efficacy (ectoparasite) - flea (3 reports), Vomiting (2 reports), Fever (1 reports), Alopecia (1 reports), Unexplained death (1 reports).
What drugs are most frequently associated with Akbash Dog adverse events?
The drugs most frequently referenced in Akbash Dog adverse event reports are Oclacitinib Maleate (2 reports), Fluralaner Chew Tablets (2 reports), Milbemycin Oxime + Spinosad (2 reports), Spinosad (2 reports), Amoxicillin (As Trihydrate); Clavulanate Potassium ( K-Clavulanate) (1 reports).
What is the average age of Akbash Dog in adverse event reports?
The average age of Akbash Dog at the time of adverse event reports is 5.2 years, with an average weight of 44.8 kg (98.8 lbs).
Does a high number of adverse event reports mean Akbash Dog is unhealthy?
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Akbash Dog safety data come from?
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.